The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A Dynamic Network Approach for the Study of Human Phenotypes
Open accessAbstract
The use of networks to integrate different genetic, proteomic, and metabolic datasets has been proposed as a viable path toward elucidating the origins of specific diseases. Here we introduce a new phenotypic database summarizing correlations obtained from the disease history of more than 30 million patients in a Phenotypic Disease Network (PDN). We present evidence that the structure of the PDN is relevant to the understanding of illness progression by showing that (1) patients develop diseases close in the network to those they already have; (2) the progression of disease along the links of the network is different for patients of different genders and ethnicities; (3) patients diagnosed with diseases which are more highly connected in the PDN tend to die sooner than those affected by less connected diseases; and (4) diseases that tend to be preceded by others in the PDN tend to be more connected than diseases that precede other illnesses, and are associated with higher degrees of mortality. Our findings show that disease progression can be represented and studied using network methods, offering the potential to enhance our understanding of the origin and evolution of human diseases. The dataset introduced here, released concurrently with this publication, represents the largest relational phenotypic resource publicly available to the research community.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
The architecture of complex weighted networks
Barrat, A., Barthélemy, M., Pastor-Satorras, R., & Vespignani, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400087101 · Cited by 4,218
Goh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M., & Barabási, A.-L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701361104 · Cited by 3,242
Self-citationTowards a proteome-scale map of the human protein–protein interaction network
Rual, J.-F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G. F., Gibbons, F. D., Dreze, M., Ayivi-Guedehoussou, N., et al. (2005) · Nature · doi:10.1038/nature04209 · Cited by 2,933
The Product Space Conditions the Development of Nations
Hidalgo, C. A., Klinger, B., Barabási, A.-L., & Hausmann, R. (2007) · Science · doi:10.1126/science.1144581 · Cited by 2,925
Self-citationThe Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,684
A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome
Stelzl, U., Worm, U., Lalowski, M., Haenig, C., Brembeck, F. H., Goehler, H., Stroedicke, M., Zenkner, M., Schoenherr, A., Koeppen, S., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.029 · Cited by 2,387
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Begovich, A. B., Carlton, V. E. H., Honigberg, L. A., Schrodi, S. J., Chokkalingam, A. P., Alexander, H. C., Ardlie, K. G., Huang, Q., Smith, A. M., Spoerke, J. M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/422827 · Cited by 1,502
A network-based analysis of systemic inflammation in humans
Program, I. A. H. R. T. I. L. S. C. R., Calvano, S. E., Xiao, W., Richards, D. R., Felciano, R. M., Baker, H. V., Cho, R. J., Chen, R. O., Brownstein, B. H., Cobb, J. P., et al. (2005) · Nature · doi:10.1038/nature03985 · Cited by 1,429
Cited by
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
Self-citationInteractome Networks and Human Disease
Vidal, M., Cusick, M. E., & Barabási, A.-L. (2011) · Cell · doi:10.1016/j.cell.2011.02.016 · Cited by 1,771
Self-citationMining electronic health records: towards better research applications and clinical care
Jensen, P. B., Jensen, L. J., & Brunak, S. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3208 · Cited by 1,680
Uncovering disease-disease relationships through the incomplete interactome
Menche, J., Sharma, A., Kitsak, M., Ghiassian, S. D., Vidal, M., Loscalzo, J., & Barabási, A.-L. (2015) · Science · doi:10.1126/science.1257601 · Cited by 1,546
Self-citationSocial contagion theory: examining dynamic social networks and human behavior
Christakis, N. A., & Fowler, J. H. (2013) · Statistics in Medicine · doi:10.1002/sim.5408 · Cited by 1,303
“We have developed and placed into the public domain much network data and code (including for the Facebook network [2], biological networks [91], experimental networks [6], and various political network datasets [9295], and we have promptly shared our code and supplementary results with anyone who has asked (e.”
Self-citationStructure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Ageing and the epidemiology of multimorbidity
Divo, M. J., Martinez, C. H., & Mannino, D. M. (2014) · European Respiratory Journal · doi:10.1183/09031936.00059814 · Cited by 701
Rappaport, N., Twik, M., Plaschkes, I., Nudel, R., Iny Stein, T., Levitt, J., Gershoni, M., Morrey, C. P., Safran, M., & Lancet, D. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1012 · Cited by 679
Human symptoms–disease network
Zhou, X., Menche, J., Barabási, A.-L., & Sharma, A. (2014) · Nature Communications · doi:10.1038/ncomms5212 · Cited by 653
Self-citationTranscription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632
“The relationships among diseases have been previously summarized as a network, termed diseasome, that is connecting them based on genetic (Goh et al., 2007) and clinical (Hidalgo et al., 2009; Zhou et al., 2014) commonalities.”
BackgroundThe Small World of Psychopathology
Borsboom, D., Cramer, A. O. J., Schmittmann, V. D., Epskamp, S., & Waldorp, L. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027407 · Cited by 591
Fabbri, E., Zoli, M., Gonzalez-Freire, M., Salive, M. E., Studenski, S. A., & Ferrucci, L. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.03.013 · Cited by 563
Jensen, A. B., Moseley, P. L., Oprea, T. I., Ellesøe, S. G., Eriksson, R., Schmock, H., Jensen, P. B., Jensen, L. J., & Brunak, S. (2014) · Nature Communications · doi:10.1038/ncomms5022 · Cited by 407
Network biology concepts in complex disease comorbidities
Hu, J. X., Thomas, C. E., & Brunak, S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.87 · Cited by 328
Aging, longevity, and healthy aging: the public health approach
Gianfredi, V., Nucci, D., Pennisi, F., Maggi, S., Veronese, N., & Soysal, P. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03021-8 · Cited by 318
Systems biology and the future of medicine
Loscalzo, J., & Barabasi, A. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.144 · Cited by 287
Using Electronic Patient Records to Discover Disease Correlations and Stratify Patient Cohorts
Roque, F. S., Jensen, P. B., Schmock, H., Dalgaard, M., Andreatta, M., Hansen, T., Søeby, K., Bredkjær, S., Juul, A., Werge, T., et al. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002141 · Cited by 282
COPD and multimorbidity: Recognising and addressing a syndemic occurrence
Fabbri, L. M., Celli, B. R., Agustí, A., Criner, G. J., Dransfield, M. T., Divo, M., Krishnan, J. K., Lahousse, L., Montes de Oca, M., Salvi, S. S., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00261-8 · Cited by 274
Population-wide analysis of differences in disease progression patterns in men and women
Westergaard, D., Moseley, P., Sørup, F. K. H., Baldi, P., & Brunak, S. (2019) · Nature Communications · doi:10.1038/s41467-019-08475-9 · Cited by 274
Asogwa, O. A., Boateng, D., Marzà-Florensa, A., Peters, S., Levitt, N., van Olmen, J., & Klipstein-Grobusch, K. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-049133 · Cited by 221
A Nondegenerate Code of Deleterious Variants in Mendelian Loci Contributes to Complex Disease Risk
Blair, D. R., Lyttle, C. S., Mortensen, J. M., Bearden, C. F., Jensen, A. B., Khiabanian, H., Melamed, R., Rabadan, R., Bernstam, E. V., Brunak, S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.030 · Cited by 215
Modules, networks and systems medicine for understanding disease and aiding diagnosis
Gustafsson, M., Nestor, C. E., Zhang, H., Barabási, A.-L., Baranzini, S., Brunak, S., Chung, K. F., Federoff, H. J., Gavin, A.-C., Meehan, R. R., et al. (2014) · Genome Medicine · doi:10.1186/s13073-014-0082-6 · Cited by 194
Self-citationHimmelstein, D. S., & Baranzini, S. E. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004259 · Cited by 172
Genomics and phenomics of body mass index reveals a complex disease network
Huang, J., Huffman, J. E., Huang, Y., Do Valle, Í., Assimes, T. L., Raghavan, S., Voight, B. F., Liu, C., Barabási, A.-L., Huang, R. D. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35553-2 · Cited by 170
Self-citationAging, frailty and complex networks
Mitnitski, A. B., Rutenberg, A. D., Farrell, S., & Rockwood, K. (2017) · Biogerontology · doi:10.1007/s10522-017-9684-x · Cited by 118
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
Morselli Gysi, D., do Valle, Í., Zitnik, M., Ameli, A., Gan, X., Varol, O., Ghiassian, S. D., Patten, J. J., Davey, R. A., Loscalzo, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025581118 · Cited by 107
Self-citationSequences of purchases in credit card data reveal lifestyles in urban populations
Di Clemente, R., Luengo-Oroz, M., Travizano, M., Xu, S., Vaitla, B., & González, M. C. (2018) · Nature Communications · doi:10.1038/s41467-018-05690-8 · Cited by 105
“We show that the selection of significant sequences is a critical step in the process; it improves the TF-IDF method that is not able to discern the spending habits within the data.”
BackgroundMethodInfluentialMapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy
Fechete, R., Heinzel, A., Perco, P., Mönks, K., Söllner, J., Stelzer, G., Eder, S., Lancet, D., Oberbauer, R., Mayer, G., et al. (2011) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201000136 · Cited by 45
“[30] introduced the Phenotypic Disease Network (PDN) as a map summarizing phenotypic connections between diseases.”
Unveiling new disease, pathway, and gene associations via multi-scale neural network
Gaudelet, T., Malod-Dognin, N., Sánchez-Valle, J., Pancaldi, V., Valencia, A., & Pržulj, N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231059 · Cited by 25
Elucidate multidimensionality of type 1 diabetes mellitus heterogeneity by multifaceted information
Chen, S.-J., Cheng, J.-L., Lee, S.-A., Wang, T.-Y., Jang, J.-Y., & Chen, K.-C. (2021) · Scientific Reports · doi:10.1038/s41598-021-00388-2 · Cited by 10
Metadata
- Authors
- Hidalgo, C. A., Blumm, N., Barabási, A.-L., & Christakis, N. A.
- Venue
- PLoS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-04-10
- Volume
- 5
- Issue
- 4
- Pages
- e1000353
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- OpenAlex
- W2152415104
- Cited by
- 674
- References
- 33
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.